Researchers – Clinical Diagnostics – Bio-Threat Detection
Faster, More Accurate Results
Imaging demands of the DNA sequencing, bio-threat, and biomedical industry demand ever faster and more accurate imaging technology. As the genomic sequencing project moves to a more advanced stage, it requires a disruptive improvement.
Enhanced Plasmonic Imaging creates images with up to 47 times more enhancement for more accurate detection. And they do this with lower costs and higher accuracy.
Spectrometry instrument companies and sensor technology companies may achieve greater market share with the Enhanced Plasmonic Imaging innovation.
This technology offers:
- Enhanced imaging quality at ultra-sensitive scales
- Much lower per unit cost of gratings
- Enhanced detection threshold of molecules at ultra-sensitive scales
DNA Sequencing Market. The technology directly enhances the DNA sequencing process through vastly enhancing the detection threshold and image contrast of biomolecules. The DNA sequencing market is expected to grow at a five-year compound annual growth rate (CAGR) of 18.7% from 2015 to 2020, reaching nearly $13.8 billion by 2020.
Global Spectrometry Market. Through its disruptive enhancement of fluorescence spectroscopy, the invention directly impacts the global spectrometry market. This market was valued at USD 12.2 billion in 2013 and is estimated to reach USD 19.6 billion by 2020 at a CAGR of 7.2% from 2014 to 2020.
Drug Identification, Food Inspection, Environmental Application and Defense Sector. These sectors benefit from handheld and portable instruments. Superior imaging quality effectively enhances onsite analysis of samples. This reduces the efforts of carrying heavy and bulky samples to laboratories for analysis. It also speeds results for faster reaction to problems or danger.